Northern Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.4M Buy
710,368
+3,596
+0.5% +$113K ﹤0.01% 1579
2025
Q1
$23.1M Sell
706,772
-10,389
-1% -$340K ﹤0.01% 1545
2024
Q4
$25.9M Buy
717,161
+110,867
+18% +$4.01M ﹤0.01% 1522
2024
Q3
$18.9M Buy
606,294
+6,775
+1% +$211K ﹤0.01% 1656
2024
Q2
$16M Sell
599,519
-19,694
-3% -$527K ﹤0.01% 1692
2024
Q1
$21.1M Sell
619,213
-29,233
-5% -$997K ﹤0.01% 1560
2023
Q4
$18.8M Sell
648,446
-85,704
-12% -$2.48M ﹤0.01% 1655
2023
Q3
$20.2M Sell
734,150
-1,438
-0.2% -$39.6K ﹤0.01% 1534
2023
Q2
$22.1M Buy
735,588
+33,169
+5% +$997K ﹤0.01% 1517
2023
Q1
$25.4M Sell
702,419
-9,918
-1% -$359K 0.01% 1396
2022
Q4
$25.4M Buy
712,337
+21,754
+3% +$776K 0.01% 1390
2022
Q3
$23.4M Sell
690,583
-748
-0.1% -$25.3K 0.01% 1357
2022
Q2
$20M Buy
691,331
+62,451
+10% +$1.81M ﹤0.01% 1523
2022
Q1
$20.3M Sell
628,880
-24,958
-4% -$807K ﹤0.01% 1661
2021
Q4
$19.1M Sell
653,838
-4,714
-0.7% -$137K ﹤0.01% 1798
2021
Q3
$17.6M Sell
658,552
-15,696
-2% -$419K ﹤0.01% 1889
2021
Q2
$20.8M Buy
674,248
+84,391
+14% +$2.6M ﹤0.01% 1858
2021
Q1
$15.4M Sell
589,857
-24,909
-4% -$652K ﹤0.01% 2010
2020
Q4
$15.5M Sell
614,766
-32,818
-5% -$826K ﹤0.01% 1973
2020
Q3
$13.5M Sell
647,584
-26,009
-4% -$542K ﹤0.01% 1910
2020
Q2
$16M Sell
673,593
-15,768
-2% -$374K ﹤0.01% 1791
2020
Q1
$12.4M Buy
689,361
+19,394
+3% +$349K ﹤0.01% 1743
2019
Q4
$15.9M Sell
669,967
-11,424
-2% -$271K ﹤0.01% 1891
2019
Q3
$18.7M Buy
681,391
+19,340
+3% +$531K ﹤0.01% 1735
2019
Q2
$21.9M Buy
662,051
+5,155
+0.8% +$171K 0.01% 1624
2019
Q1
$23M Buy
656,896
+3,609
+0.6% +$126K 0.01% 1563
2018
Q4
$21.7M Sell
653,287
-5,983
-0.9% -$199K 0.01% 1518
2018
Q3
$33.2M Buy
659,270
+22,673
+4% +$1.14M 0.01% 1362
2018
Q2
$38.1M Buy
636,597
+22,151
+4% +$1.33M 0.01% 1247
2018
Q1
$28.1M Sell
614,446
-30,216
-5% -$1.38M 0.01% 1433
2017
Q4
$25.7M Sell
644,662
-3,238
-0.5% -$129K 0.01% 1521
2017
Q3
$25.9M Sell
647,900
-5,362
-0.8% -$214K 0.01% 1522
2017
Q2
$28.2M Buy
653,262
+17,836
+3% +$769K 0.01% 1421
2017
Q1
$19.9M Buy
635,426
+10,208
+2% +$320K 0.01% 1637
2016
Q4
$15.8M Sell
625,218
-141,796
-18% -$3.58M ﹤0.01% 1770
2016
Q3
$19M Buy
767,014
+120,562
+19% +$2.98M 0.01% 1632
2016
Q2
$13.2M Buy
646,452
+128,078
+25% +$2.61M ﹤0.01% 1831
2016
Q1
$7.82M Buy
518,374
+114,771
+28% +$1.73M ﹤0.01% 2129
2015
Q4
$5.42M Buy
403,603
+20,424
+5% +$274K ﹤0.01% 2414
2015
Q3
$5.38M Buy
383,179
+32,320
+9% +$453K ﹤0.01% 2399
2015
Q2
$5.96M Buy
350,859
+37,836
+12% +$643K ﹤0.01% 2415
2015
Q1
$3.78M Buy
313,023
+21,386
+7% +$259K ﹤0.01% 2686
2014
Q4
$2.42M Sell
291,637
-15,831
-5% -$131K ﹤0.01% 2982
2014
Q3
$2.67M Buy
307,468
+71,498
+30% +$621K ﹤0.01% 2905
2014
Q2
$2.58M Buy
235,970
+33,102
+16% +$362K ﹤0.01% 2931
2014
Q1
$1.81M Sell
202,868
-21,119
-9% -$189K ﹤0.01% 3185
2013
Q4
$1.69M Buy
223,987
+24,384
+12% +$184K ﹤0.01% 3230
2013
Q3
$1.46M Buy
199,603
+93,365
+88% +$684K ﹤0.01% 3222
2013
Q2
$683K Buy
+106,238
New +$683K ﹤0.01% 3388